10 Comments

  1. PomegranateAfter3330 on

    Would be curious to hear peoples opinions on where they think the marketing went astray.

  2. nicolasb51942003 on

    I genuinely thought this could see a big boost because of goodwill from the first one, just like how Saw and Paranormal Activity jumped a massive amount with their second film on opening weekend.

  3. Key-Payment2553 on

    That would not be that good compared to the original Smile which had $2.2M previews and an opening weekend of $22.6M

    The sequel would have $2M previews and an opening weekend of $15M-$20M which is less then its predecessor

  4. On the bright side this isn’t the type of movie to be pre-sale heavy anyways . I think it’ll benefit heavily from walk-ups like the first film. I’m still thinking $25M OW

  5. Confirms what I’ve been saying. All the smart people in their gutted marketing division are working on Sanic. For Parker’s sake, I hope strong reviews and great word of mouth can make up for the difference.

  6. There’s a lot that went wrong here. Terrifier played the Paranormal Activity to the franchise’s Saw, swooping in and stealing much of the horror audience. Paramount started marketing too early and didn’t ramp up a good hook for quite a while. (A dude banging his head with a weight? That’s laughable compared to the jump scares in the marketing for the first one.) I assume the downer ending of the first and the grim as night vibes of the franchise make it hard to be “excited” for. Even the “horror/thriller at a pop concert” angle isn’t fresh because of Trap.

    I still see this one having walkup business, especially if the early reviews saying it’s more of the good stuff from the first one hold up, but it’s clear it can’t perform like the first. (Which was really a marvel of the post-pandemic box office, so I’m not over here expecting two lightning strikes.)

Leave A Reply